Differential downstream signaling in microglia lacking Alzheimer's-related TREM2 or its adaptor TYROBP/DAP12

Gabriela E Farias Quipildor1,2,3, Ramona Belfiore1,2,3,4, Khaled Althobaiti1

  • 1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.

Molecular Neurodegeneration Advances
|February 9, 2026
PubMed

Insights

TREM2 and TYROBP are crucial for microglial activation and homeostasis. Their absence alters microglial response to stimuli, impacting brain immunity and neurodegenerative disease pathways.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are brain immune cells with diverse activation states.
  • TREM2 and TYROBP proteins form a complex regulating microglial transitions.
  • Understanding TREM2/TYROBP mechanisms is key to neuroinflammation and neurodegenerative diseases.

Purpose of the Study:

  • Investigate the roles of TREM2 and TYROBP in microglial activation.
  • Elucidate downstream signaling pathways regulated by TREM2/TYROBP.
  • Determine how TREM2/TYROBP influence microglial response to stimuli.

Main Methods:

  • Isolated primary microglia from wild-type, Trem2 KO, and Tyrobp KO mice.
  • Stimulated microglia with amyloid beta (Aβ) or lipopolysaccharide (LPS).
  • Analyzed protein and gene expression, cell morphology, and signaling pathways.

Main Results:

  • Absence of TREM2 or TYROBP increased basal phosphorylated ERK levels.
  • TREM2/TYROBP deficiency led to altered baseline microglial morphology.
  • Stimulation with Aβ or LPS induced differential gene and protein expression in KO microglia.

Conclusions:

  • TREM2 and TYROBP are essential for microglial homeostasis and activation.
  • These proteins regulate downstream signaling and morphology in response to stimuli.
  • Findings shed light on microglial dysfunction in neuroinflammation and Alzheimer's disease.